BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
BDSX on Nasdaq
Shares outstanding
153,159,065
Price per share
$7.55
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
286,804
Total reported value
$2,165,370
% of total 13F portfolios
0%
Share change
-35,325,739
Value change
-$49,572,483
Number of holders
1
Price from insider filings
$7.55
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SCHULER JACK W 26% +5.2% $17,919,611 +$1,569,767 39,821,357 +9.6% SCHULER JACK W 29 Aug 2025
PERCEPTIVE ADVISORS LLC 5.1% +12% $4,374,112 +$570,000 7,673,880 +15% Perceptive Advisors LLC 12 May 2025

As of 30 Sep 2025, 1 institutional investors reported holding 286,804 shares of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX). This represents 0.19% of the company’s total 153,159,065 outstanding shares.

Institutional Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 286,804 $2,165,370 -$49,572,483 $7.55 1
2025 Q2 35,612,549 $10,048,893 -$8,584,445 $0.28 40
2025 Q1 53,381,433 $33,366,627 -$3,868,068 $0.63 59
2024 Q4 58,649,814 $89,679,455 -$7,997,947 $1.53 57
2024 Q3 62,218,930 $110,921,906 +$15,266,061 $1.78 52
2024 Q2 53,436,850 $81,777,752 +$57,322,390 $1.53 45
2024 Q1 16,006,662 $22,884,313 -$1,588,245 $1.43 40
2023 Q4 16,417,872 $30,182,879 -$441,307 $1.84 37
2023 Q3 16,667,385 $27,458,475 -$284,228 $1.65 35
2023 Q2 16,839,117 $20,710,989 +$99,218 $1.23 27
2023 Q1 16,664,539 $30,995,409 +$1,071,172 $1.86 29
2022 Q4 16,040,137 $36,890,775 +$25,970,234 $2.30 31
2022 Q3 4,753,051 $6,041,815 +$1,219,601 $1.27 22
2022 Q2 3,721,910 $5,990,000 -$721,904 $1.64 33
2022 Q1 4,117,236 $6,955,000 -$1,332,541 $1.69 35
2021 Q4 3,976,513 $21,018,000 -$678,693 $5.29 37
2021 Q3 4,243,618 $34,897,000 -$13,519,998 $8.22 41
2021 Q2 5,120,544 $67,642,000 +$8,671,926 $13.21 46
2021 Q1 4,216,600 $85,636,000 +$9,214,109 $20.31 45
2020 Q4 3,764,855 $75,347,064 +$75,347,096 $20.16 44